Gastric Emptying Recovery After GLP-1 RA Cessation
A legfontosabb adatok
- Ki végzi
- Wonkwang University Hospital
- Hol
- Dél-Korea2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 186 fő vett részt
- Kezdés
- 2025. nov. 20.
- Befejezés
- 2026. jan. 12.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A vizsgált kezelések
- Preoperative gastric ultrasound
- A regiszteradat frissítve
- 2026. január 23.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Adults aged ≥18 years
- Receiving a glucagon-like peptide-1 receptor agonist (GLP-1 RA)
- Scheduled for elective surgery under general anesthesia
- Able to provide written informed consent
Ki nem vehet részt
- Prior gastric or esophageal surgery
- Emergency surgery
- Severe gastroesophageal reflux disease
- Known gastroparesis
- Pregnancy
- Inability to provide informed consent
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can delay gastric emptying and may increase residual gastric contents before general anesthesia. Current perioperative recommendations for withholding GLP-1 RAs (e.g., a fixed 7-day discontinuation for weekly agents) are largely consensus-based, and it is unclear whether gastric emptying normalizes abruptly after a single threshold interval. This prospective observational cohort study will evaluate how preoperative residual gastric content changes with increasing time since the last GLP-1 RA dose, using point-of-care gastric ultrasound performed immediately before induction of anesthesia. Time since last dose will be analyzed as a continuous exposure and across prespecified intervals (≤3 days, 4-7 days, ≥8 days). The primary outcome is ultrasound-estimated gastric volume normalized to body weight (mL/kg), derived from antral cross-sectional area. Secondary outcomes include the presence of a "high-risk stomach" based on gastric volume criteria and qualitative ultrasound findings. The study will also assess whether body mass index modifies the relationship between cessation interval and gastric volume, thereby supporting individualized perioperative risk assessment.
A vizsgálat 3 csoportja
- GLP-1 RA cessation ≤3 days
Participants using GLP-1 receptor agonists whose last dose was taken ≤3 days before the preoperative gastric ultrasound assessment (performed immediately prior to induction of anesthesia).
Kezelés: Preoperative gastric ultrasound
- GLP-1 RA cessation 4-7 days
Participants using GLP-1 receptor agonists whose last dose was taken 4-7 days before the preoperative gastric ultrasound assessment (performed immediately prior to induction of anesthesia).
Kezelés: Preoperative gastric ultrasound
- GLP-1 RA cessation ≥8 days
Participants using GLP-1 receptor agonists whose last dose was taken ≥8 days before the preoperative gastric ultrasound assessment (performed immediately prior to induction of anesthesia).
Kezelés: Preoperative gastric ultrasound
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Time-dependent Recovery of Gastric Emptying After Cessation of Glucagon-like Peptide-1 Receptor Agonists: a Prospective Observational Gastric Ultrasound Study
- A regiszteradat frissítve
- 2026. január 23.